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Abstract 30 
Anxiety-related disorders are severe psychiatric conditions that involve complex 31 
physiological and behavioral maladaptive responses. The use of conspecific alarm 32 
substance (CAS) for inducing anxiety-like behaviors in fish species provides important 33 
translational insights of how aversive conditions modulate neurobehavioral functions. 34 
Because nicotine may elicit anxiolytic-like responses, here we investigated whether acute 35 
nicotine exposure prevents CAS-induced anxiogenic-like behaviors in zebrafish. We used 36 
both novel tank and light-dark tests as two well-established paradigms for measuring 37 
anxiety-like behavior. Fish were individually exposed to 1 mg/L nicotine or non-38 
chlorinated water for 3 min and then transferred to other tanks in the absence or presence 39 
of 3.5 mL/L CAS for 5 min. Later, the behavior of fish was tested in the novel tank test 40 
or in the light-dark preference test. As expected, CAS triggered aversive behaviors by 41 
increasing bottom dwelling, freezing, erratic movements, scototaxis, and risk assessment 42 
episodes. Nicotine alone elicited anxiolytic-like behaviors, since it increased the time 43 
spent in top area, as well as the average duration of entry in the lit compartment. 44 
Moreover, nicotine pretreatment prevented CAS-induced aversive responses without 45 
changing locomotion, suggesting that anxiolysis could play a role, at least in part, to the 46 
behavioral effects of nicotine observed here. Overall, these novel findings show 47 
beneficial effects of nicotine on anxiogenic responses in zebrafish. We also reinforce the 48 
practical advantages of this aquatic species to explore the relieving properties of nicotine, 49 
as well as to understand the neurobiological bases involved in anxiety-related disorders 50 
and associated therapeutic targets. 51 
 52 
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1. Introduction 55 
Anxiety-related disorders are one of the most prevalent psychiatric conditions 56 
worldwide, with multiple genetic and environmental determinants (Bartlett et al., 2017; 57 
Bishop, 2007). Psychological and physical symptoms include muscular tension, 58 
irritability, agitation, concentration problems, palpitations, dizziness, and epigastric 59 
discomfort (Peres et al., 2017; Shoham et al., 2018). Mounting evidence suggests that 60 
different neurotransmitter systems, including the cholinergic neurotransmission, 61 
modulate anxiety-like behaviors (File et al., 2000b; Zarrindast and Khakpai, 2015). 62 
Nicotine influences a large number of physiological processes, such as learning 63 
and memory, locomotion, and anxiety (Jones et al., 1999; Zarrindast and Khakpai, 2018; 64 
Ziani et al., 2018). This molecule is an alkaloid extracted from the tobacco plant 65 
(Powledge, 2004) composed of pyridine and a pyrrolidine ring [1-methyl-2-(3-pyridyl) 66 
pyrrolidine], which binds to nicotinic acetylcholine receptors (nAChRs) (Lester et al., 67 
2009). As an agonist of nAChRs, nicotine elicits various effects on the central nervous 68 
system (CNS) depending on site and receptor composition (Bencan and Levin, 2008; File 69 
et al., 2000a). A dualistic role of nicotine has been shown in experimental models, where 70 
it promotes anxiolysis or anxiogenic-like effects following acute and chronic exposure, 71 
respectively (Falco and Bevins, 2015; Singer et al., 2016; Stewart et al., 2015). 72 
Although rodents have been widely used to assess the effects of nicotine on 73 
anxiety-related behaviors, there is a growing utility of zebrafish (Danio rerio) models in 74 
translational neuropsychiatric research (Fontana et al., 2018; Stewart et al., 2014). The 75 
advantages that make zebrafish an excellent tool include the efficient rate of absorption 76 
of substances through water (de Abreu et al., 2018), their evolutionarily conserved 77 
neurotransmitter systems when compared to the mammalian counterparts (Rico et al., 78 
2011), their well-characterized behaviors (Kalueff et al., 2013), and the pharmacological 79 
4 
 
sensitivity to anxiolytic and anxiogenic drugs (Egan et al., 2009; Mezzomo et al., 2018; 80 
Rosemberg et al., 2012). Moreover, the presence of lateral pallium and habenula, 81 
analogous brain structures to mammalian hippocampus and amygdala, respectively, 82 
makes zebrafish a suitable model organism to investigate the neural bases of emotion and 83 
aversive responses (Champagne et al., 2010; Fontana et al., 2018).  84 
In zebrafish, the conspecific alarm substance (CAS) exposure elicits anxiety-like 85 
behaviors (Canzian et al., 2017; Speedie and Gerlai, 2008). This substance is released 86 
when epidermal club cells are injured, reflecting a potential predator risk (Quadros et al., 87 
2016). CAS triggers exacerbated defensive behaviors, as well as prolonged aversive 88 
responses (Lima et al., 2016; Maximino et al., 2018). Two well-established models for 89 
measuring anxiety-like behavior are the novel tank diving test (Egan et al., 2009; Levin 90 
et al., 2007) and the light-dark preference test (Maximino et al., 2010). While in the first 91 
task animals show a typical geotaxis and gradually habituate to novelty stress (Wong et 92 
al., 2010), in the light-dark test, zebrafish usually prefers the dark compartment of the 93 
apparatus, thereby facilitating crypsis (Maximino et al., 2010). Anxiolytic drugs increase 94 
the exploration of the lit area, whereas anxiogenic compounds exacerbate dark preference 95 
as a protective response (Mezzomo et al., 2016).   96 
Because nicotine acutely induces anxiolysis in zebrafish, (Klee et al., 2011; 97 
Levin et al., 2007; Singer et al., 2016), we hypothesize the occurrence of relieving 98 
properties of nicotine when fish are challenged with an acute chemical stressor. 99 
Thus, the goal of our study was to investigate whether a short-term nicotine exposure 100 
prevents CAS-induced anxiogenic-like behaviors in zebrafish using the novel tank and 101 
the light-dark preference tests.   102 
 103 
2. Methods 104 
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2.1. Animals and housing 105 
Subjects were adult zebrafish (Danio rerio, 3–4 months-old) from the short-fin 106 
phenotype (~50:50 male:female ratio) obtained from a local distributor (Hobby Aquários, 107 
RS, Brazil). Fish were kept in 40 L tanks at a maximum density of 2 fish per liter and 108 
acclimatized in the laboratory for two weeks before the experiments. Tanks were 109 
maintained under constant aeration and mechanical filtration and the water temperature 110 
was set at 27 ± 1ºC, pH 7.0–7.2. Room illumination was provided by fluorescent light 111 
tubes with photoperiod 14h light and 10h dark. Animals were fed thrice daily with 112 
commercial flake fish food (Alcon BASICTM, Alcon, Brazil). After the experiments, fish 113 
were anesthetized in water at 4°C and then euthanized by section of the spinal cord. 114 
Animals were maintained in accordance with the National Institute of Health Guide for 115 
Care and Use of Laboratory Animals. Experiments were run in multiple days using 116 
three independent batches to ensure data reproducibility. All experimental protocols 117 
were approved by the Ethics Commission on Animal Use of the Federal University of 118 
Santa Maria (protocol number 6894010616). 119 
 120 
2.2. Nicotine exposure 121 
S(-)-Nicotine (98%) was purchased from Sigma-Aldrich™ (St. Louis, MO, USA). 122 
Fish were exposed to 1 mg/L of nicotine added in tank water for 3 min as described 123 
elsewhere (Singer et al., 2016; Ziani et al., 2018). Later, animals were exposed to CAS 124 
and behavioral tests were performed. Control group was handled in a similar manner but 125 
kept in non-chlorinated water in the absence of nicotine. 126 
 127 
2.3. Conspecific alarm substance preparation 128 
Conspecific alarm substance was extracted from donor fish previously euthanized. 129 
Briefly, fish were placed in a Petri dish kept on ice and CAS were obtained through 10-130 
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15 superficial shallow cuts in epidermal cells with a razor blade (Egan et al., 2009; Lima 131 
et al., 2016; Quadros et al., 2016). Animals were then washed on both sides with 10 mL 132 
of distilled water per fish for preparing a CAS stock solution. The exposure was 133 
performed using 3.5 mL/L of CAS solution for 5 min, which elicits robust defensive 134 
responses in zebrafish (Canzian et al., 2017; Maximino et al., 2018; Speedie and Gerlai, 135 
2008). For control group, only distilled water was added in the experimental tanks. Fig. 136 
1 summarizes all experimental procedures, behavioral tests, and the groups assessed.    137 
 138 
2.4. Behavioral analyses 139 
All behaviors were recorded for 6 min using a webcam connected to a laptop at 140 
30 frames/s with appropriate video-tracking software (Any-MazeTM, Stoelting, CO, 141 
USA). Importantly, all treatments described above were run in a randomized order 142 
and fish were not originated from the same housing tank. Randomization was 143 
performed using a computerized random number generator (www.random.org) and 144 
a 50:50 male:female ratio was separated per group. Because the exposure tanks were 145 
assigned by a code (performed by a researcher who did not participate in the 146 
experiments), investigators were blind to the experimental conditions. Codification 147 
was revealed only when data were analyzed. Two experimental apparatus were used 148 
per group and since no tank effects or gender influence were observed (data not 149 
shown), data were pooled for subsequent analyses. 150 
  151 
2.4.1. Novel tank diving test 152 
After the exposure period, fish were individually transferred to the novel tank 153 
apparatus (25 cm length x 15 cm height x 6 cm width), which was virtually divided in 154 
two segments (bottom area and top area) and filled with 2 L home tank water. Locomotor 155 
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activity and vertical explorations were measured during habituation to novelty (Egan et 156 
al., 2009; Levin et al., 2007; Rosemberg et al., 2011) and the following endpoints were 157 
determined: distance traveled, absolute turn angle, maximum speed, transitions and time 158 
spent in top, latency to enter the top, number and duration of freezing, number and 159 
duration of erratic movements. The absolute turn angle reports the sum of the absolute 160 
angle between each movement vector of the animal, with anti-clockwise movement 161 
being negative and clockwise movement being positive (i.e. the angle is from -180° 162 
to 180°). Freezing was defined as a complete immobility of fish (≥ 2 s) with concomitant 163 
increased opercular beat rate, while erratic movements were defined as fast swimming 164 
bouts with sudden changes in direction (Kalueff et al., 2013). Both freezing and erratic 165 
movements were manually counted by two trained observers (inter-rater reliability ≥ 166 
0.85) blinded to the experimental condition of fish.   167 
     168 
2.4.2. Light-dark test 169 
Following nicotine and CAS exposure period, fish were individually transferred 170 
to the light-dark tank based on the protocol described elsewhere (Maximino et al., 2010). 171 
The apparatus (25 cm length × 10 cm depth × 15 cm height) was divided into two equally 172 
sized compartments by opaque self-adhesive plastic in white and black colors, covering 173 
the floor and walls. The respective behaviors were assessed: time spent in lit area, 174 
shuttling, average duration of entry in the lit area, and number of risk assessments. A risk 175 
assessment episode was defined as a fast (≤ 1 s) or partial entry into the lit area with a 176 
subsequent return to the dark compartment, which reflects a conflict between the 177 
motivation to explore and avoid unknown environments (Kalueff et al., 2013). Risk 178 
assessment episodes were manually counted by two trained observers (inter-rater 179 
reliability ≥ 0.85) blinded to the experimental condition.   180 
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 181 
2.5. Statistical analyses 182 
Sample sizes were estimated a priori based on pilot experiments using G-183 
Power 3.1 software. For the novel tank test, we considered an alpha = 0.05, 184 
power = 0.85, and effect size = 0.4 (resulting in n = 14 per group), while for the light-185 
dark test we considered an alpha = 0.05, power = 0.85, and effect size = 0.5 (resulting 186 
in n = 10 per group). Normality of data and homogeneity of variances were analyzed 187 
using Kolmogorov–Smirnov and Bartlett's tests, respectively. Due to the parametric 188 
distribution and data homoscedasticity, results were expressed as means ± standard 189 
error of means (S.E.M.) and analyzed by two-way analysis of variance (ANOVA), 190 
followed by Student-Newman-Keuls multiple comparison test whenever necessary. 191 
The inter-rater reliability was estimated using Spearman correlation and all significances 192 
were set at p ≤ 0.05.  193 
 194 
3. Results 195 
3.1. Nicotine prevents CAS-induced aversive responses without changing locomotion 196 
Fig. 2 shows the behavioral effects of nicotine and CAS in the novel tank test. 197 
Independently of the treatment, no significant changes were observed in locomotor-198 
related parameters (Fig. 2A). Regarding the vertical activity (Fig. 2B), nicotine 199 
increased the time spent in top (F(1,53) = 25.57, p < 0.0001) and prevented CAS-200 
induced effects on this behavior (F(1,53) = 16.83, p = 0.0001 for the interaction term). 201 
Both CAS and NIC/CAS groups showed reduced transitions to top area (F(1,53) = 202 
17.01, p = 0.0001) and CAS also increased the latency to enter the top (F(1,53) = 8.172, 203 
p = 0.0061) when compared to control. Fig. 3 shows the effects of nicotine and CAS on 204 
aversive behaviors. We observed a significant nicotine x CAS interaction for the 205 
number (F(1,53) = 5.189, p = 0.0268) and duration of freezing (F(1,53) = 13.05, p = 206 
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0.0007), as well as for the number (F(1,53) = 9.792, p = 0.0028), and duration of erratic 207 
movements (F(1,53) = 8.394, p = 0.0055). In general, CAS increased defensive behaviors 208 
and nicotine prevented these effects.     209 
 210 
3.2. Nicotine prevents CAS-induced exacerbation on scototaxis 211 
Fig. 4 shows the behavioral effects of nicotine and CAS in the light-dark 212 
apparatus. CAS decreased the time spent in lit area, while nicotine showed a 213 
preventive effect on this behavioral endpoint (F(1,36) = 5.099, p = 0.0301 for the 214 
interaction term). Nicotine-treated fish showed reduced shuttling (F(1,36) = 12.04, p = 215 
0.0014) and increased average duration of entry in the lit area in the absence and presence 216 
of CAS (F(1,36) = 15.37, p = 0.0004). Nicotine also abolished the effects of CAS on the 217 
number of risk assessment episodes (F(1,36) = 8.655, p = 0.0056, for the interaction 218 
term).  219 
 220 
4. Discussion 221 
The current study examined the behavioral effects of nicotine pretreatment on 222 
CAS-induced aversive responses in zebrafish. Evidence shows that acute nicotine 223 
treatment in this aquatic species positively modulates cognitive responses and exerts 224 
anxiolytic-like responses in various behavioral tasks (Eddins et al., 2009; Levin et al., 225 
2007; Singer et al., 2016; Ziani et al., 2018). Since CAS exacerbates defensive behaviors, 226 
it has been considered a chemical cue that elicits behavioral phenotypes that closely 227 
parallel those observed in patients with anxiety-, stress- and/or trauma-related disorders 228 
(Canzian et al., 2017; Lima et al., 2016; Maximino et al., 2018). To our knowledge, our 229 
data represent the first evidence showing that nicotine prevents anxiogenic-like behaviors 230 
in zebrafish, possibly due to its anxiolytic actions following an acute exposure. 231 
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In the last decade, zebrafish has emerged as an attractive model organism in 232 
psychiatry and translational neuroscience research to investigate the neural bases 233 
involved in anxiety-like responses (Fontana et al., 2018; Stewart et al., 2014). The novel 234 
tank and the light-dark tests are suitable protocols to evaluate defensive responses in 235 
zebrafish (Maximino et al., 2012). While in the novel tank diving test the motivational 236 
aspect is surface escaping (Blaser and Rosemberg, 2012), the main stimulus in the light-237 
dark test is scototaxis (Maximino et al., 2012). Similar to previous findings, we observed 238 
that CAS-exposed fish exhibit typical behavioral patterns during habituation to novelty 239 
stress, such as increased erratic movements, freezing, and geotaxis (Quadros et al., 2016; 240 
Speedie and Gerlai, 2008). Zebrafish also showed robust scototaxis, as well as more risk 241 
assessment episodes in the light-dark test. These set of data reflect typical behavioral 242 
patterns associated with anxiety-like responses following acute CAS exposure. 243 
Importantly, nicotine-treated fish showed increased the average duration of entry in the 244 
lit area in the light-dark test and spent more time in top area in the novel tank diving test, 245 
suggesting anxiolysis. Moreover, nicotine pretreatment abolished CAS-mediated 246 
responses, revealing a preventive effect on aversive behaviors. Because CAS and nicotine 247 
did not affect locomotion, the responses measured here reflect changes on anxiety-like 248 
behaviors instead of a simple modulation of motor patterns. 249 
 Evidence shows that CAS is naturalistic alarm cue responsible for 250 
triggering alarm reactions in ostariophysian (Maximino et al., 2018; Quadros et al., 251 
2016). Although its exact chemical composition has not been fully elucidated, 252 
aversive responses are attributed to the presence of hypoxanthine 3-N-oxide and 253 
chondroitin sulphate, which show similar effects when tested alone (Parra et al., 254 
2009). Importantly, the occurrence of aversive behaviors (e.g., freezing, erratic 255 
movements, and bottom-dwelling) is highly reproducible in the literature (Canzian 256 
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et al., 2017; Egan et al., 2009; Maximino et al., 2018). A single CAS exposure elicits 257 
prolonged avoidance to the conditioning side in the conditioned place aversion 258 
paradigm, possibly due to a time-dependent sensitization of stress response (Lima et 259 
al., 2016; Maximino et al., 2018) . Thus, different from other anxiogenic agents, a 260 
brief CAS exposure normally induces prominent behavioral phenotypes paralleling 261 
those observed in post-traumatic stress disorder (Lima et al., 2016). Although the 262 
mechanisms underlying the behavioral effects of CAS are still poorly explored, an 263 
involvement of the CNS in CAS-mediated behaviors has been postulated. For 264 
example, CAS activates c-fos expression in habenula, a brain region responsible for 265 
fear responses in the teleost fish (Ogawa et al., 2014). Various signaling molecules, 266 
such as biogenic amines, amino acids, peptides, and steroids play a role in anxiety, 267 
thereby modulating defensive behaviors (Benson et al., 2015; Strohle and Holsboer, 268 
2003). In zebrafish, CAS acutely activates sympathetic nervous system and increases 269 
whole-body cortisol, blood glucose, norepinephrine, and epinephrine, as well as 270 
serotonin and 5-hydroxyindoleacetic acid levels in the CNS, culminating in ‘fight or 271 
flight’ responses (Maximino et al., 2014; Mezzomo et al., 2019; Quadros et al., 2018). 272 
Furthermore, an influence of cholinergic system in aversive responses of zebrafish 273 
is predicted, since CAS increases acetylcholinesterase activity in the brain (Canzian 274 
et al., 2017) and nicotine facilitates contextual fear conditioning following a single 275 
exposure to alarm cues (Ziani et al., 2018). These set of data reinforce the growing 276 
utility of CAS as a naturalistic stimulus to model alarm reactions and aversive 277 
responses in translational neurobehavioral research. 278 
Anxiolytic compounds are commonly used to reduce the frequency of aversive 279 
behaviors. In humans, smoking is considered a key factor to minimize anxiety due to the 280 
relieving properties of nicotine (Fidler and West, 2009). Nicotine may promote anxiolysis 281 
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or anxiogenesis depending on the species, concentration, administration route, and 282 
exposure period (Sackerman et al., 2010; Zarrindast and Khakpai, 2018). Acutely, the 283 
activation of nAChRs also facilitates the release of GABA (Maggi et al., 2001), which 284 
could play a role in anxiolytic effects of nicotine (Sullivan and Covey, 2002). Similar to 285 
mammals, zebrafish show high sensitivity to nicotine, which elicits consistent and robust 286 
anxiolytic-like responses following acute exposure (Levin et al., 2007; Sackerman et al., 287 
2010; Singer et al., 2016). Importantly, the administration of methyllycaconitine and 288 
dihydro-β-erythroidine increases bottom dwelling in the presence of nicotine, implying a 289 
key role of both α7 and α4β2 nicotinic receptors in nicotine-mediated anxiolysis (Bencan 290 
and Levin, 2008). Since most neuronal nAChRs in the brain modulate the release of 291 
various neurotransmitters that influence mood and anxiety (e.g., aetylcholine, 292 
serotonin, glutamate, and dopamine) (Dani and Bertrand, 2007), the underlying 293 
mechanisms involved in the preventive role of nicotine against CAS-mediated 294 
responses still require further scrutiny.  295 
 296 
5. Conclusion 297 
To our knowledge, this is the first study showing a positive effect of nicotine on 298 
anxiogenic responses in zebrafish, supporting the growing utility of this aquatic species 299 
to investigate the neurobehavioral effects of nicotine in vertebrates. Because distinct 300 
neurotransmitter systems regulate anxiety, thereby modulating defensive behaviors, the 301 
use of zebrafish is a promising tool to assess the molecular mechanisms underlying 302 
nicotine-mediated anxiolysis. Our results also further support a deeper 303 
pharmacological investigation of the cholinergic signaling as a potential mechanism 304 
associated to fear responses in translational neuropsychiatric research. Overall, 305 
paralleling clinical and rodent studies, our data strengthen the beneficial properties of 306 
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nicotine in zebrafish, reinforcing practical advantages to explore the neurobiological 307 
bases involved in emotional impairments and correlated behaviors. 308 
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Figures 471 
 472 
Fig. 1. Schematic representation of the experimental design and behavioral tests used for 473 
assessing the effects of nicotine on CAS-induced anxiogenic-like responses.  474 
 475 
Fig. 2. Locomotor and exploratory activities of zebrafish in the novel tank test. (A) 476 
Locomotion-related behavioral endpoints. (B) Vertical exploration. Data were expressed 477 
as means ± S.E.M. and analyzed by two-way ANOVA, followed by Student-Newman-478 
Keuls multiple comparison test whenever necessary (* p < 0.05; ** p < 0.01; *** p < 479 
0.005, n = 14 per group). 480 
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 481 
Fig. 3. Preventive effects of nicotine on CAS-induced aversive behaviors. Data were 482 
expressed as means ± S.E.M. and analyzed by two-way ANOVA, followed by Student-483 
Newman-Keuls multiple comparison test whenever necessary (* p < 0.05; ** p < 0.01; 484 
*** p < 0.005; **** p < 0.001, n = 14 per group). 485 
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 486 
Fig. 4. Effects of nicotine and CAS on scototaxis. Data were expressed as means ± S.E.M. 487 
and analyzed by two-way ANOVA, followed by Student-Newman-Keuls multiple 488 
comparison test whenever necessary (* p < 0.05; ** p < 0.01, n = 10 per group).   489 
